One more point for ibrutinib plus rituximab over fludarabine, cyclophosphamide and rituximab (FCR)
@article{ACTR9985,
author = {Martin Gauthier and Christian Koba},
title = {One more point for ibrutinib plus rituximab over fludarabine, cyclophosphamide and rituximab (FCR)},
journal = {AME Clinical Trials Review},
volume = {2},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9985}
}